glp 1 cardiovascular disease 💉 GLP-1's have been FDA approved for over 20 years. 🫀 They have been found to improve overall health and reduce the risk of cardiovascular disease. 🧬 Obesity is a complex Figure 1 from Cardiovascular Effects

Barretts esophagus without dysplasia wont affect you much

GLP-1RA therapies are commonly prescribed for weight-loss and to manage blood sugar levels in people with Type 2 diabetes

The administration does not currently approve the peptide for human use (Technically, no one is allowed to market it for consumer use, though that hasn't stopped people from purchasing research-grade peptides meant only for laboratory use on the gray market)

A peptide storage case is supplied separately for laboratories consolidating cold-chain inventory

CagriSema, a fixeddose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg for weight loss and type 2 diabetes, has a similar side effect profile to other GLP1 receptor agonists